Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+149.2%
5Y CAGR+132.2%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+149.2%/yr
vs +25.4%/yr prior
5Y CAGR
+132.2%/yr
Recent acceleration
Acceleration
+123.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
67.4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $66.82M | +61.3% |
| 2024 | $41.44M | +208.4% |
| 2023 | $13.44M | +211.2% |
| 2022 | $4.32M | +2649.7% |
| 2021 | $157000.00 | -84.2% |
| 2020 | $991000.00 | -71.4% |
| 2019 | $3.46M | +97.9% |
| 2018 | $1.75M | +6623.1% |
| 2017 | $26000.00 | -29.7% |
| 2016 | $37000.00 | - |